메뉴 건너뛰기




Volumn 21, Issue 2, 2011, Pages 56-60

Newborn screening for inborn errors of metabolism: Principles, policies and weighing the evidence

Author keywords

Genetic testing; Health policy; Healthcare evaluation mechanisms; High throughput screening assays; Infant, newborn; Mass screening; Metabolism, inborn errors; Neonatal screening; Public health practice; Tandem mass spectrometry

Indexed keywords

ASSAY; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; GENETIC SCREENING; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HIGH THROUGHPUT SCREENING; HUMAN; INBORN ERROR OF METABOLISM; MASS SCREENING; MEDICAL DECISION MAKING; MEDICAL ETHICS; NEWBORN; NEWBORN SCREENING; PRACTICE GUIDELINE; REVIEW; SCREENING TEST; TANDEM MASS SPECTROMETRY; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

EID: 79951476185     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2010.10.011     Document Type: Review
Times cited : (3)

References (7)
  • 1
    • 33747591403 scopus 로고    scopus 로고
    • Newborn screening panel and system
    • ACMG Newborn Screening Expert Group
    • ACMG Newborn Screening Expert Group Newborn screening panel and system. Genet Med 2006, 8:1S-252S.
    • (2006) Genet Med , vol.8
  • 2
    • 33747878216 scopus 로고    scopus 로고
    • What is the clinical utility of genetic testing?
    • Grosse S.D., Khoury M.J. What is the clinical utility of genetic testing?. Genet Med 2006 Jul, 8:448-450.
    • (2006) Genet Med , vol.8 , pp. 448-450
    • Grosse, S.D.1    Khoury, M.J.2
  • 5
    • 79951468886 scopus 로고    scopus 로고
    • National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. London: Department of Health, (accessed Sep 2010).
    • National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. London: Department of Health, 2003. (accessed Sep 2010). http://www.library.nhs.uk/screening.
    • (2003)
  • 6
    • 79952198744 scopus 로고    scopus 로고
    • Expanded newborn screening: reducing harm, assessing benefit
    • Wilcken B. Expanded newborn screening: reducing harm, assessing benefit. J Inherit Metab Dis 2010, 10.1007/s10545-010-9106-6.
    • (2010) J Inherit Metab Dis
    • Wilcken, B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.